Private Advisor Group’s Apyx Medical APYX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-66,720
Closed -$143K 2631
2025
Q3
$143K Sell
66,720
-223,111
-77% -$472K ﹤0.01% 2381
2025
Q2
$652K Buy
289,831
+1,855
+0.6% +$2.61K ﹤0.01% 1548
2025
Q1
$395K Sell
287,976
-23,068
-7% -$31.8K ﹤0.01% 1729
2024
Q4
$491K Sell
311,044
-11,277
-3% -$15.8K ﹤0.01% 1586
2024
Q3
$400K Buy
322,321
+12,180
+4% +$15.4K ﹤0.01% 1744
2024
Q2
$416K Buy
+310,141
New +$457K ﹤0.01% 1664

Other funds holding APYX

Private Advisor Group's APYX Position: Q4 2025 in Review

Private Advisor Group sold out of Apyx Medical (APYX) in Q4 2025, closing a stake of 66,720 shares — an estimated $143K sold.

Private Advisor Group first reported a position in APYX in Q2 2024 and held it in 6 quarters. The position peaked at $652K in Q2 2025. 59 funds tracked by Wall St. Rank hold APYX as of Q4 2025.

  • Private Advisor Group reported no remaining Apyx Medical position as of Q4 2025 after selling out during the quarter.
  • Private Advisor Group sold 66,720 Apyx Medical shares in Q4 2025, an estimated $143K.
  • Private Advisor Group first reported a position in Apyx Medical in Q2 2024 and held it in 6 quarters.
  • Private Advisor Group's Apyx Medical position peaked at $652K in Q2 2025.
  • 59 funds tracked by Wall St. Rank held Apyx Medical as of Q4 2025.

Based on Private Advisor Group's 13F filing for Q4 2025, filed 17 Feb 2026.